All Stories

  1. Derivation of CYP3A4 and CYP2B6 degradation rate constants in primary human hepatocytes: A siRNA-silencing-based approach

    Article • Drug Metabolism and Pharmacokinetics, March 2018, Elsevier

    Neill Liptrott

  2. Lack of interaction of lopinavir solid drug nanoparticles with cells of the immune system

    Article • Nanomedicine, September 2017, Future Medicine

    Neill Liptrott

  3. In vitro characterisation of solid drug nanoparticle compositions of efavirenz in a brain endothelium cell line

    Article • Journal of Interdisciplinary Nanomedicine, September 2017, Wiley

    Professor Steven P Rannard, Dr David Dickens, Neill Liptrott, Alison Savage, James Hobson

  4. Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensions

    Article • Nanomedicine, May 2015, Future Medicine

    Neill Liptrott

  5. Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter

    Article • Frontiers in Pharmacology, April 2015, Frontiers

    Neill Liptrott

  6. Partial mitigation of gold nanoparticle interactions with human lymphocytes by surface functionalization with a ‘mixed matrix’

    Article • Nanomedicine, November 2014, Future Medicine

    Dr Daniel James Nieves, Neill Liptrott

  7. Rilpivirine Inhibits Drug Transporters ABCB1, SLC22A1, and SLC22A2In Vitro

    Article • Antimicrobial Agents and Chemotherapy, September 2013, ASM Journals

    Neill Liptrott

  8. Antiretroviral Solid Drug Nanoparticles with Enhanced Oral Bioavailability: Production, Characterization, and In Vitro-In Vivo Correlation

    Article • Advanced Healthcare Materials, September 2013, Wiley

    Tom McDonald, Neill Liptrott

  9. Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulation

    Article • Journal of Antimicrobial Chemotherapy, June 2013, Oxford University Press (OUP)

    Neill Liptrott

  10. Research Spotlight: Nanomedicines for HIV therapy

    Article • Therapeutic Delivery, February 2013, Future Science

    Tom McDonald, Neill Liptrott

  11. Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS

    Article • Pharmacogenetics and Genomics, January 2012, Wolters Kluwer Health

    Neill Liptrott

  12. IFN-γ 874A>T Genotype Is Associated With Higher CCR5 Expression in Peripheral Blood Mononuclear Cells From HIV+ Patients

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2011, Wolters Kluwer Health

    Neill Liptrott

  13. Plasma and Intracellular Pharmacokinetics of Darunavir/Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected Individuals

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, December 2011, Wolters Kluwer Health

    Neill Liptrott

  14. Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction

    Article • The Journal of Infectious Diseases, July 2011, Oxford University Press (OUP)

    Neill Liptrott, Dr. Vicente Soriano

  15. The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?

    Article • Expert Opinion on Drug Metabolism & Toxicology, February 2011, Informa Healthcare

    Neill Liptrott

  16. Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir

    Article • Antimicrobial Agents and Chemotherapy, November 2010, ASM Journals

    Neill Liptrott

  17. Plasma and Intracellular (Peripheral Blood Mononuclear Cells) Pharmacokinetics of Once-Daily Raltegravir (800 Milligrams) in HIV-Infected Patients

    Article • Antimicrobial Agents and Chemotherapy, October 2010, ASM Journals

    Neill Liptrott

  18. HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

    Article • Pharmacogenetics and Genomics, February 2010, Wolters Kluwer Health

    Neill Liptrott

  19. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC

    Article • British Journal of Pharmacology, February 2009, Wiley

    Neill Liptrott

  20. Detection of ABCC2, CYP2B6 and CYP3A4 in human peripheral blood mononuclear cells using flow cytometry

    Article • Journal of Immunological Methods, December 2008, Elsevier

    Neill Liptrott